|MEDTRONIC PLC filed this Form SC 13G/A on 09/15/2017|
Mazor Robotics Ltd.
PO Box 3104
5 Shacham St.
Caesarea North Industrial Park
Covidien Group S.a.r.l.
Medtronic plc (Medtronic) and its wholly-owned subsidiary, Covidien Group S.a.r.l. (Covidien), are jointly filing this Amendment No. 1 (this Amendment) to the Statement of Beneficial Ownership on Schedule 13G filed on August 22, 2016 (the Statement) to report their acquisition, on September 12, 2017, of (i) an additional 1,040,106 American Depositary Shares (ADSs), which represent 2,080,212 ordinary shares, and (ii) warrants (Warrants) to purchase an additional 1,210,000 ADSs, or 2,420,000 ordinary shares, which together with their preexisting holdings, have increased their holdings above 10% of the outstanding ordinary shares of the Issuer. Covidien holds all of such ADSs and Warrants directly, while Medtronic may be deemed to share beneficial ownership over all of such ADSs and Warrants by virtue of its control of Covidien.
Medtronic: 20 Lower Hatch Street, Dublin 2, Ireland
Covidien: 3b, Bd. Prince Henri, 4th Floor L-1724 Luxembourg
American Depository Shares, represented by American Depository Receipts, each representing two Ordinary Shares, par value NIS 0.01 per share
Page 4 of 7